Influence of Blood Coagulation Factor XIII and FXIII Val34Leu on Plasma Clot Formation Measured by Thrombelastography

This publication has 20 references indexed in Scilit:

• Examining Thrombin Hydrolysis of the Factor XIII Activation Peptide Segment Leads to a Proposal for Explaining the Cardioprotective Effects Observed with the Factor XIII V34L Mutation
  Journal of Biological Chemistry, 2000
• Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease
  New England Journal of Medicine, 2000
• The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction
  Blood, 2000
• The FXIII Val 34 Leu Mutation and the Risk of Venous Thrombosis
  Thrombosis and Haemostasis, 2000
• Prevalence of Three Common Polymorphisms in the A-subunit Gene of Factor XIII in Patients with Coronary Artery Disease
  Thrombosis and Haemostasis, 1999
• Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males
  Atherosclerosis, 1999
• The role of factor XIIIVal34Leu in cardiovascular disease
  QJM: An International Journal of Medicine, 1999
• Association of a Common Polymorphism in the Factor XIII Gene With Venous Thrombosis
  Blood, 1999
• Human Procarboxypeptidase U, or Thrombin-activable Fibrinolysis Inhibitor, Is a Substrate for Transglutaminases
  Journal of Biological Chemistry, 1998
• Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
  Journal of Clinical Investigation, 1980